Type 2 Diabetes

A study comparing patients with and those without type 2 diabetes found patients with diabetes had significantly higher rates of AKI than those without the condition.

Adults with type 2 diabetes who were hospitalized with COVID-19 in northern Italy had a lower mortality rate and better health outcomes when treated with the DPP-IV inhibitor sitagliptin, according to study data published in Diabetes Care.

The efficacy of an investigational, once-weekly insulin therapy was similar to daily insulin glargine in patients with type 2 diabetes, according to data from a phase 2 trial. It was the top story in endocrinology last week.

South Asian and African Caribbean adults living in north west London are more likely to be diagnosed with early-onset type 2 diabetes than white adults, according to a speaker.

Among adults with type 2 diabetes, risks for vascular and nonvascular dementias increase with HbA1c levels, but Alzheimer’s risk appears to increase only with very HbA1c, according to registry data from Sweden.

Not only is obstructive sleep apnea an independent risk factor for type 2 diabetes — with stronger associations as apnea severity increases — but diabetes is a risk factor for sleep apnea, according to results of a meta-analysis.

Exposure to diabetes in utero was associated with an elevated risk for CVD events and risk factors in offspring from the ages of 10 to 35 years, according to research published in CMAJ.

New exploratory analyses show treatment with the SGLT2 inhibitor ertugliflozin reduced risk for worsening kidney function, dialysis or renal death among adults with type 2 diabetes compared with placebo.

Adults with diabetes in the United Kingdom live fewer years on average than people without diabetes and 100 days for each year an HbA1c above 7.5%, according to study data.

Among people with type 2 diabetes, those with increased exercise capacity had a significantly decreased risk for all-cause mortality, according to data presented at the virtual European Association for the Study of Diabetes annual meeting.